CORRELATION OF DIASTOLIC BLOOD PRESSURE WITH HIGH SENSITIVITY C-REACTIVE PROTEIN IN MIDDLE AGED CORONARY HEART DISEASE PATIENTS
DOI:
https://doi.org/10.69656/pjp.v20i2.1650Keywords:
coronary heart disease, high sensitivity C reactive protein, Diastolic blood pressure, Cardiovascular disease, Blood pressureAbstract
Background and objectives: C-reactive protein is a plasma protein to determine the levels of inflammation inside our body. There are low levels of CRP in our blood but moderate to severe elevated levels can be seen in bacterial infection and any other autoimmune diseases. Hypertension is considered to be the significant risk factor in coronary heart disease. Our objective of study is to determine the correlation of hs-CRP with diastolic blood pressure in middle aged coronary heart disease individuals.
Methods: This is a descriptive cross sectional study conducted among two groups i.e coronary heart disease and control (n=150). Their CRP levels as well as two readings of diastolic blood pressure are taken. Data and results collected, compiled and analyzed with SPSS version 23.
Results: Hypertension is an important risk factor for coronary events. Results of our study has shown strong correlation between CRP and diastolic blood pressure having mean values about 146.3±2.14 (P< 0.001) in coronary heart disease individuals and 92.14±17.14 in control group ( P value 0.008).
Conclusion: It was observed that hs-crp has strong association with diastolic blood pressure in middle aged coronary heart disease individuals.
Downloads
References
Plebani M. Why C-reactive protein is one of the most requested tests in clinical laboratories? Clin Chem Lab Med 2023;61(9):1540–5.
Miura D, Motohashi S, Goto A, Kimura H, Tsugawa W, Sode K, et al. Rapid and convenient single-chain variable fragment-employed electrochemical c-reactive protein detection system. Int J Mol Sci 2024;25(5):2859.
Slevin M, Matou-Nasri S, Turu M, Luque A, Rovira N, Badimon L, Boluda S, Potempa L, Sanfeliu C, de Vera N, Krupinski J. Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol 2010;20(1):151–65.
Sproston NR, Ashworth JJ. Role of C-reactive protein at Sites of Inflammation and Infection. Front Immunol 2018;9:754.
Daskalopoulou SS, Rabi DM, Schiffrin EL, Feldman RD, Padwal RS, Tremblay G, Khan NA; Hypertension Canada. Hypertension Guidelines in the United States and Canada: Are We Getting Closer? Hypertension 2018;71(6):976-978.
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387(10022):957–67.4
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34(28):2159–219.
Shu W, Jing J, Fu LC, Min JT, Bo YX, Ying Z, et al. The relationship between diastolic pressure and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Am J Hypertens 2013;26(5):630–5.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol 2020;76(25):2982–3021.
Crea F. The burden of cardiovascular risk factors: a global perspective. Eur Heart J 2022;43(30):2817–20.
Gao Y, Wang M, Wang R, Jiang J, Hu Y, Wang W, et al. The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study. Lipids Health Dis 2024;23(1):66.
Aziz D, Imdad KM, Afraa Z. Association of high sensitivity c-reactive protein (Hs-CRP) with poor glycaemic control and coronary heart disease in type 2 diabetes mellitus. Res J Pharm Technol 2023;16(1):193–9.
Guo X, Ma L. Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol–related inflammatory parameters as predictors. Coron Artery Dis 2023;34(1):66–77.
Attiq A, Afzal S, Ahmad W, Kandeel M. Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol 2024:176338.
Mohammadnia N, Opstal TSJ, El Messaoudi S, Bax WA, Cornel JH. An update on inflammation in atherosclerosis: how to effectively treat residual risk. Clin Ther 2023;45(11):1055–9.
Akimova NS, Shvarts YG, Mikhel ND, Kiselev AR, Ledvanova TY, Konshina LE, et al. The severity of chronic heart failure and the parameters of daily blood pressure profile in patients with coronary heart disease. Explor Med 2024;5(1):101–11.
Civieri G, Kerkhof PLM, Montisci R, Iliceto S, Tona F. Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation. Atherosclerosis 2023;384:117276.
Yano Y, Kim HC, Lee H, Azahar N, Ahmed S, Kitaoka K, et al. Isolated diastolic hypertension and risk of cardiovascular disease: controversies in hypertension-pro side of the argument. Hypertension 2022;79(8):1563–70.
Xie M, Xie D, Yang Y, Zhang Y, Li K, Zhou B, et al. Association of high-sensitivity C-reactive protein in middle-aged and elderly Chinese people with hyperuricaemia and risk of coronary heart disease: a cross-sectional study. BMJ Open 2019;9(10):e028351.
Liu Y, Jia SD, Yao Y, Tang XF, Xu N, Jiang L, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2020;75(1):60–65.
Zhao H, Lu Y, Niu J, Bian H, Kuang X, Age-independent association between high- sensitivity C-reactive protein and blood pressure in middle aged adults. Vojnosani Pregl 2023;80(11):915–20.
Kurl S, Jae SY, Voutilainen A, Mäkikallio T, Laukkanen JA. Joint effect of blood pressure and C-reactive protein and the risk of sudden cardiac death: A prospective cohort study. Int J Cardiol 2021;326:184–8.
Bautista LE, López-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001;19(5):857–61.
Chuang SY, Hsu PF, Chang HY, Bai CH, Yeh WT, Pan HW, C-reactive protein predicts systolic blood pressure and pulse pressure but not diastolic blood pressure: the cardiovascular disease risk factors two-township study, Am J Hypertens 2013;26(5):657–64.
Bautista LE, Atwood JE, O’Malley PG, Taylor AJ. Association of C-reactive protein and hypertension in healthy middle aged men and women. Coron Artery Dis 2004;15(6);331–6.
Liu HH, Cao YX, Sun D, Jin JL, Zhang HW, Guo YL, et al. High sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes. Hypertens Res 2019;42(11):1783–93.
Chen B, Cui Y, Lei M, Xu W, Yan Q, Zhang X, et al. C-reactive protein levels in relation to incidence of hypertension in chineese adults: longitudinal analysis from the china health and nutrition survey. Int J Hypertens 2021;2021:3326349.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.
